Study confirms high success rates of combined chemotherapy in treating testicular cancer

FHS
July 20, 2024
2:48 am

A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after first-line treatment fails.

Humana & Strive Health Offers Value-Based Kidney Care to More Medicare Advantage Members

What You Should Know: – Humana Inc. (NYSE: HUM) and kidney care provider Strive Health announced today a new multi-state, value-based care agreement for kidney

March 6, 2024

The problem with potential changes to the biosimilar regulatory framework

Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price

September 26, 2023

Study reveals disparities in emergency department restraint use by race and ethnicity

A new study that contributes additional data to a growing body of evidence demonstrating disparities in restraint use in the emergency department (ED) has been

January 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.